P29590 (PML_HUMAN) Homo sapiens (Human)
Protein PML UniProtKBInterProSTRINGInteractive Modelling
882 aa; Sequence (Fasta) ; (Isoform 8; Isoform 9; Isoform 5; Isoform 2; Isoform 4; Isoform 10; Isoform 3; Isoform 11; Isoform 12; Isoform 13; Isoform 14)
Available Structures
19 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of K46-acetylated SUMO1 in complex with PML-SIM |
Heteromer P63165; | |||||
| Assess | ||||||
| Crystal structure of K46-acetylated SUMO1 in complex with phosphorylated PML-SIM |
Heteromer P63165; | |||||
| Assess | ||||||
| Crystal structure of K39-acetylated SUMO1 in complex with PML-SIM |
Heteromer P63165; | |||||
| Assess | ||||||
| Crystal structure of K45-acetylated SUMO1 in complex with PML-SIM |
Heteromer P63165; | |||||
| Assess | ||||||
| Crystal structure of K39-acetylated SUMO1 in complex with phosphorylated PML-SIM |
Heteromer P63165; | |||||
| Assess | ||||||
| Ternary complex of SUMO1 with the SIM of PML and zinc |
Heteromer P63165; | 3×ZN; | ||||
| Assess | ||||||
| Crystal Structure of SUMO1 in complex with PML |
Heteromer P63165; | |||||
| Assess | ||||||
| Crystal structure of SUMO1 in complex with phosphorylated PML |
Heteromer P63165; | |||||
| Assess | ||||||
| Ternary complex of SUMO1 with a phosphomimetic SIM of PML and zinc |
Heteromer P63165; | 4×ZN; | ||||
| Assess | ||||||
| Crystal structure of K37-acetylated SUMO1 in complex with phosphorylated PML-SIM |
Heteromer P63165; | |||||
| Assess | ||||||
| Crystal structure of K37-acetylated SUMO1 in complex with PML-SIM |
Heteromer P63165; | |||||
| Assess | ||||||
| Crystal structure of K45-acetylated SUMO1 in complex with phosphorylated PML-SIM |
Heteromer P63165; | |||||
| Assess | ||||||
| Crystal Structure of PML RING tetramer | homo-4-mer | 8×ZN; | ||||
| Assess | ||||||
| Crystal structure of PML B1-box multimers | homo-2-mer | 4×ZN; 1×CL; | ||||
| Assess | ||||||
| Solution structure of the TRIM19 B-box1 (B1) of human promyelocytic leukemia (PML) | homo-2-mer | 4×ZN; | ||||
| Assess | ||||||
| TRANSCRIPTION FACTOR PML, A PROTO-ONCOPROTEIN, NMR, 1 REPRESENTATIVE STRUCTURE AT PH 7.5, 30 C, IN … | monomer | 2×ZN; | ||||
| Assess | ||||||
| The RING Domain of human Promyelocytic Leukemia Protein (PML) | monomer | 2×ZN; | ||||
| Assess | ||||||
| Crystal structure of PML B-box2 | monomer | 1×GLC; 2×ZN; | ||||
| Assess | ||||||
| Crystal structure of PML B-box2 mutant | monomer | 1×GLC; 2×ZN; | ||||
| Assess | ||||||
18 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 6j9r.1.A | homo-2-mer | 0.63 | 14.29 | ||
| Assess | ||||||
| Isoform 2 | 6wi7.1.A | monomer | 0.55 | 3×ZN; | 19.80 | |
| Assess | ||||||
| Isoform 3 | 6j9r.1.A | homo-2-mer | 0.58 | 14.29 | ||
| Assess | ||||||
| Isoform 4 | 6j9r.1.A | homo-2-mer | 0.61 | 14.29 | ||
| Assess | ||||||
| Isoform 4 | 6wi7.1.A | monomer | 0.53 | 3×ZN; | 19.80 | |
| Assess | ||||||
| Isoform 5 | 6wi8.1.A | monomer | 0.50 | 2×ZN; | 19.80 | |
| Assess | ||||||
| Isoform 8 | 6j9r.1.A | homo-2-mer | 0.58 | 14.29 | ||
| Assess | ||||||
| Isoform 8 | 5olm.1.A | homo-2-mer | 0.51 | 4×ZN; | 21.43 | |
| Assess | ||||||
| Isoform 9 | 6j9r.1.A | homo-2-mer | 0.64 | 14.29 | ||
| Assess | ||||||
| Isoform 9 | 6wi7.1.A | monomer | 0.51 | 3×ZN; | 19.80 | |
| Assess | ||||||
| Isoform 10 | 6j9r.1.A | homo-2-mer | 0.65 | 14.29 | ||
| Assess | ||||||
| Isoform 10 | 6wi7.1.A | monomer | 0.52 | 3×ZN; | 19.80 | |
| Assess | ||||||
| Isoform 12 | 6j9r.1.A | homo-2-mer | 0.58 | 14.29 | ||
| Assess | ||||||
| Isoform 12 | 6wi7.1.A | monomer | 0.54 | 3×ZN; | 19.80 | |
| Assess | ||||||
| Isoform 13 | 6j9r.1.A | homo-2-mer | 0.61 | 14.15 | ||
| Assess | ||||||
| Isoform 14 | 6j9r.1.A | homo-2-mer | 0.64 | 14.29 | ||
| Assess | ||||||
| Isoform 14 | 6wi7.1.A | monomer | 0.53 | 3×ZN; | 19.80 | |
| Assess | ||||||
| Isoform 14 | 5olm.1.A | homo-2-mer | 0.50 | 4×ZN; | 21.43 | |
| Assess | ||||||